Amicus Therapeutics Stock

Amicus Therapeutics Employees 2024

Amicus Therapeutics Employees

584

Ticker

FOLD

ISIN

US03152W1099

WKN

A0MSMZ

In 2024, Amicus Therapeutics employed 584 people, a 0% change from the 584 number of employees in the previous year.

Amicus Therapeutics Aktienanalyse

What does Amicus Therapeutics do?

Amicus Therapeutics Inc. is a biopharmaceutical company specializing in the development of drugs for the treatment of rare diseases. The company was founded in 2002 and is headquartered in Cranbury, New Jersey. Amicus Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Amicus Therapeutics's Employee Base

Amicus Therapeutics's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Amicus Therapeutics's operational capacity and future potential.

Year-to-Year Comparison

Assessing Amicus Therapeutics's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Amicus Therapeutics's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Amicus Therapeutics’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Amicus Therapeutics stock

How many employees does Amicus Therapeutics have this year?

Amicus Therapeutics has 584 undefined employees this year.

How many employees did Amicus Therapeutics have compared to the previous year?

Compared to the previous year, Amicus Therapeutics had 0% more employees.

What impact did the number of employees have on the company Amicus Therapeutics?

The number of employees has a direct impact on the efficiency and productivity of Amicus Therapeutics. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Amicus Therapeutics?

The number of employees can also have an impact on investors of Amicus Therapeutics, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Amicus Therapeutics affect the company?

An increase in equity of Amicus Therapeutics can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Amicus Therapeutics's equity affect the company?

A reduction in equity of Amicus Therapeutics can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Amicus Therapeutics?

Some factors that can influence the equity of Amicus Therapeutics include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Amicus Therapeutics so important for investors?

The equity of Amicus Therapeutics is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Amicus Therapeutics influence the company?

The number of employees at Amicus Therapeutics can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Amicus Therapeutics evolved in recent years?

In recent years, the number of employees at Amicus Therapeutics has changed by 0.

How many employees does Amicus Therapeutics currently have?

Amicus Therapeutics currently has 584 undefined employees.

Why is the number of employees important for investors of Amicus Therapeutics?

The number of employees is important for investors of Amicus Therapeutics as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Amicus Therapeutics take to change the number of employees?

To change the number of employees, Amicus Therapeutics can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Amicus Therapeutics pay?

Over the past 12 months, Amicus Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Amicus Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Amicus Therapeutics?

The current dividend yield of Amicus Therapeutics is .

When does Amicus Therapeutics pay dividends?

Amicus Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Amicus Therapeutics?

Amicus Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Amicus Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Amicus Therapeutics located?

Amicus Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Amicus Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Amicus Therapeutics from 7/16/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/16/2024.

When did Amicus Therapeutics pay the last dividend?

The last dividend was paid out on 7/16/2024.

What was the dividend of Amicus Therapeutics in the year 2023?

In the year 2023, Amicus Therapeutics distributed 0 USD as dividends.

In which currency does Amicus Therapeutics pay out the dividend?

The dividends of Amicus Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Amicus Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Amicus Therapeutics

Our stock analysis for Amicus Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Amicus Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.